Osimertinib and EGFR T790M resistance: a third-generation inhibitor
A detailed look at how osimertinib overcame resistance to earlier targeted therapies and changed the landscape of lung cancer treatment.
DR
By Dr. Nancy Kapadia
Health Library · Condition Hub
Oncology
Plain-English explanations of targeted cancer therapies, kinase inhibitors, and supportive care medicines.
5 articles
Showing
1–5
of 5
Venetoclax in CLL: how BCL-2 inhibition works
Discover how venetoclax forces cancer cells to undergo natural cell death by targeting the BCL-2 protein in chronic lymphocytic leukaemia.
DR
By Dr. Hari Ramalingam
Imatinib (Gleevec generic): how this targeted therapy works
Imatinib was the first targeted cancer drug to prove that blocking a single abnormal protein could put leukaemia into remission.
DR
By Dr. Lipika Sachdeva
Understanding Cancer: Types, Causes, and Modern Treatment Options
Learn about the different types of cancer, what causes them, and the modern treatment options available today.
DR
By Dr. Chitra Shetty
Cancer Medicines Explained: How Oncology Drugs Work
Understand how cancer medicines work, from chemotherapy to targeted therapy, and explore affordable oncology drug options.
DR
By Dr. A. Srinivasan